journal article·2015-10Open access

Endogenous Stimuli‐Sensitive Multistage Polymeric Micelleplex Anticancer Drug Delivery System for Efficient Tumor Penetration and Cellular Internalization

Junjie Li, Wendong Ke, Hui Li, Zengshi Zha, Yu Han, Zhishen Ge

Advanced Healthcare Materials· Volume 4· Issue 15

Abstract

To efficiently deliver anticancer drugs to the entire tumor tissue and cancer cells, an endogenous stimuli‐sensitive multistage polymeric micelleplex drug delivery system is developed via electrostatic complexation between poly(ethylene glycol)‐block‐poly[(N′‐dimethylmaleoyl‐2‐aminoethyl)aspartamide]‐block‐poly(ε‐caprolactone) (PEG‐b‐PAsp(EDA‐DM)‐b‐PCL) triblock copolymer micelles and cisplatin prodrug (Pt(IV))‐conjugated cationic poly(amidoamine) dendrimers (PAMAM‐Pt(IV)). The micelleplexes maintain structural stability at pH 7.4 ensuring long blood circulation and high tumor accumulation level, while they exhibit triggered release of secondary PAMAM‐Pt(IV) dendrimer nanocarriers at tumoral acidity (≈pH 6.8) due to acid‐labile charge‐reversal properties of PAsp(EDA‐DM) component under mildly acidic condition. The released PAMAM delivery nanocarriers with small size and slightly positive charges exhibit significantly deep tumor tissue penetration and efficient cellular internalization, followed by release of active cisplatin anticancer drug in intracellular reducing medium. In vivo investigation reveals that the Pt(IV)‐loading micelleplexes significantly suppress tumor growth via intravenous injection due to synergistic effect of long circulation in bloodstream, high tumor accumulation, deep tumor tissue penetration, and efficient cellular internalization. Thus, the micelleplexes with stimuli‐responsive multistage release feature show great potentials for better therapeutic efficacy of cancer especially through enhanced tumor penetration and cellular internalization.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Soft Matter Chemistry Chinese Academy of Sciences Department of Polymer Science and Engineering University of Science and Technology of China Hefei Anhui 230026 China

Funding

National Natural Scientific Foundation of China · Foundation for the Author of National Excellent Doctoral Dissertation of P. R. China · Fundamental Research Funds for the Central Universities

References (64)

Show source-provided references
1. 10.1016/j.jconrel.2014.06.04210.1016/j.jconrel.2014.06.042 ↗
2. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
3. 10.1038/nrd261410.1038/nrd2614 ↗
4. 10.1038/nrd108810.1038/nrd1088 ↗
5. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
6. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
7. 10.1016/j.jconrel.2012.05.04210.1016/j.jconrel.2012.05.042 ↗
8. 10.1016/j.nantod.2014.04.00810.1016/j.nantod.2014.04.008 ↗
9. 10.1002/adma.20120208010.1002/adma.201202080 ↗
10. 10.1200/JCO.2005.04.93710.1200/JCO.2005.04.937 ↗
11. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
12. 10.1093/annonc/mdh09710.1093/annonc/mdh097 ↗
13. 10.1038/nrc189310.1038/nrc1893 ↗
14. Boucher Y. · Cancer Res. · 1990 · 50 · 4478
15. 10.1038/nrc249910.1038/nrc2499 ↗
16. 10.1038/nature0756710.1038/nature07567 ↗
17. 10.1126/science.118305710.1126/science.1183057 ↗
18. 10.1073/pnas.061166010410.1073/pnas.0611660104 ↗
19. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
20. 10.1021/nn301282m10.1021/nn301282m ↗
21. 10.1021/nn500299p10.1021/nn500299p ↗
22. 10.1021/bm401526d10.1021/bm401526d ↗
23. 10.1088/0957-4484/16/7/02410.1088/0957-4484/16/7/024 ↗
24. 10.1021/nl900031y10.1021/nl900031y ↗
25. 10.1021/nl052241g10.1021/nl052241g ↗
26. 10.1002/adhm.20120046710.1002/adhm.201200467 ↗
27. 10.1002/anie.20131122710.1002/anie.201311227 ↗
28. 10.1016/j.jconrel.2014.05.00610.1016/j.jconrel.2014.05.006 ↗
29. 10.1021/ja211888a10.1021/ja211888a ↗
30. 10.1073/pnas.101838210810.1073/pnas.1018382108 ↗
31. 10.1039/C3PY01277H10.1039/C3PY01277H ↗
32. 10.1039/C4CC03120B10.1039/C4CC03120B ↗
33. 10.1016/j.biomaterials.2013.12.09610.1016/j.biomaterials.2013.12.096 ↗
34. 10.1016/j.biomaterials.2013.06.05810.1016/j.biomaterials.2013.06.058 ↗
35. 10.1002/adfm.20090082510.1002/adfm.200900825 ↗
36. 10.1021/ja207150n10.1021/ja207150n ↗
37. 10.1002/anie.20090721010.1002/anie.200907210 ↗
38. 10.1039/C3TB21383H10.1039/C3TB21383H ↗
39. 10.1002/anie.20025065310.1002/anie.200250653 ↗
40. 10.1021/ma050752j10.1021/ma050752j ↗
41. 10.1016/j.biomaterials.2011.06.07210.1016/j.biomaterials.2011.06.072 ↗
42. 10.1021/ja071090b10.1021/ja071090b ↗
43. 10.1021/bm100396s10.1021/bm100396s ↗
44. 10.1021/nn901403210.1021/nn9014032 ↗
45. 10.1016/j.addr.2012.01.00710.1016/j.addr.2012.01.007 ↗
46. 10.1073/pnas.080915410510.1073/pnas.0809154105 ↗
47. 10.1039/c0cs00097c10.1039/c0cs00097c ↗
48. 10.1016/j.addr.2005.09.01710.1016/j.addr.2005.09.017 ↗
49. 10.1073/pnas.101137910810.1073/pnas.1011379108 ↗
50. 10.1016/j.jconrel.2014.12.02210.1016/j.jconrel.2014.12.022 ↗
51. Yellepeddi V. K. · J. Biotechnol. Biomaterial. · 2013
52. 10.1016/j.biomaterials.2012.05.04910.1016/j.biomaterials.2012.05.049 ↗
53. 10.1002/anie.20131070910.1002/anie.201310709 ↗
54. 10.1038/bjc.1989.14810.1038/bjc.1989.148 ↗
55. Busch T. M. · Cancer Res. · 2002 · 62 · 7273
56. 10.1038/nmat379210.1038/nmat3792 ↗
57. 10.1021/ar200094a10.1021/ar200094a ↗
58. 10.1016/j.addr.2011.09.00910.1016/j.addr.2011.09.009 ↗
59. 10.1038/nmat377610.1038/nmat3776 ↗
60. 10.1002/adhm.20110000810.1002/adhm.201100008 ↗
61. 10.1002/adma.20140155410.1002/adma.201401554 ↗
62. 10.1039/c2cs15344k10.1039/c2cs15344k ↗
63. 10.1016/S0031-6997(24)01494-710.1016/S0031-6997(24)01494-7 ↗
64. 10.1038/nnano.2008.3410.1038/nnano.2008.34 ↗